Search results
Dr. Walensky is currently Principal Investigator and Attending Physician in the Department of Pediatric Oncology at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Professor Pediatrics at Harvard Medical School; and Director of the Harvard/MIT MD-PhD Program.
Loren David Walensky is an American physician-scientist and pediatric oncologist at the Dana–Farber Cancer Institute since 2003 and a professor of pediatrics at the Dana–Farber/Harvard Cancer Center. He researches peptides and oncogenic pathways. In 2013, Walensky became director of the joint MD/PhD program at Harvard Medical School.
- 3
- .mw-parser-output .marriage-line-margin2px{line-height:0;margin-bottom:-2px}.mw-parser-output .marriage-line-margin3px{line-height:0;margin-bottom:-3px}.mw-parser-output .marriage-display-ws{display:inline;white-space:nowrap}, Rochelle Walensky (m. 1995)
Loren D. Walensky, MD, PhD. Physician. Principal Investigator, Linde Program in Cancer Chemical Biology. Professor of Pediatrics, Harvard Medical School. Appointment Phone. 888-733-4662 (New Pediatric Patients) 617-632-3270 (Established Pediatric Patients) Fax. 617-582-8240. General. Treatment Centers. Pediatric Hematologic Malignancies. Discipline
People also ask
Who is Loren David Walensky?
Who is Larry Walensky and what does he do?
Who is Dr Walensky?
What does the Walensky laboratory do?
May 1, 2019 · Loren David Walensky, M.D., Ph.D. Professor of Pediatrics. 617-355-6369. Email. Publications View. Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice. Authors: Authors: Mourtada R, Herce HD, Yin DJ, Moroco JA, Wales TE, Engen JR, Walensky LD. Nat Biotechnol 2019-10-01.
2010. The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members. GL Verdine, LD Walensky. Clinical cancer research 13 (24), 7264-7270. , 2007. 472. 2007. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.
Loren David Walensky. The Walensky laboratory focuses on the chemical biology of deregulated apoptotic and transcriptional pathways in cancer. Our goal is to develop an arsenal of new compounds-a “chemical toolbox”-to investigate and block protein interactions that cause cancer.
Loren Walensky. MD, PhD. Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Director, Harvard/MIT MD-PhD Program. Professor of Pediatrics, Harvard Medical School. Request an Appointment. Phone: 888-733-4662. Fax: 617-582-8240. NPI: 1508896853. Print Profile. Locations. Boston.
Related searches
